Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 20/20 | 1.00 |
| ▸ | TYK2 | P29597 | 19/20 | 1.00 |
| ▸ | JAK1 | P23458 | 14/20 | 1.00 |
| ▸ | JAK2 | O60674 | 13/20 | 1.00 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.71 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18260341 | 1.00 | JAK3 (1.00) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL29566062 | 1.00 | JAK3 (1.00) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL18269703 | 1.00 | JAK3 (1.00) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL18260339 | 1.00 | JAK3 (1.00) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL24995473 | 0.86 | TYK2 (0.75) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL18260449 | 0.86 | TYK2 (0.82) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL18260446 | 0.86 | TYK2 (0.82) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL26323063 | 0.85 | JAK3 (0.78) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL21676052 | 0.85 | TYK2 (0.73) | JAK3TYK2JAK1JAK2P2RX3 | |
| SCHEMBL21229652 | 0.85 | TYK2 (0.78) | JAK3TYK2JAK1JAK2P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3569604-A1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS | Theravance Biopharma R&D IP, LLC (US) | 2019-11-20 | — | — | EP | disclosed |